Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-05-21 @ 1:06 PM
Study NCT ID:
NCT04630769
Status:
COMPLETED
Last Update Posted:
2023-04-03
First Post:
2020-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
FT516 and IL2 With Enoblituzumab for Ovarian Cancer
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization: